140 related articles for article (PubMed ID: 30379097)
1. The determinants, biomarkers, and consequences of microvascular injury in kidney transplant recipients.
Doreille A; Dieudé M; Cardinal H
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F9-F19. PubMed ID: 30379097
[TBL] [Abstract][Full Text] [Related]
2. Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantation.
Wewers TM; Mayer AB; Pfleiderer A; Beul K; Schmidt R; Heitplatz B; Van Marck V; Nolte I; Pavenstädt H; Reuter S; Brand M; Di Marco GS
Kidney Int; 2019 May; 95(5):1091-1102. PubMed ID: 30824181
[TBL] [Abstract][Full Text] [Related]
3. Reviewing the pathogenesis of antibody-mediated rejection and renal graft pathology after kidney transplantation.
Morozumi K; Takeda A; Otsuka Y; Horike K; Gotoh N; Narumi S; Watarai Y; Kobayashi T
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():4-8. PubMed ID: 26971899
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathological analyses of transplant glomerulopathy cases.
Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
[TBL] [Abstract][Full Text] [Related]
5. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
[TBL] [Abstract][Full Text] [Related]
6. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
[TBL] [Abstract][Full Text] [Related]
7. Subclinical peritubular capillaritis at 3 months is associated with chronic rejection at 1 year.
Lerut E; Naesens M; Kuypers DR; Vanrenterghem Y; Van Damme B
Transplantation; 2007 Jun; 83(11):1416-22. PubMed ID: 17565313
[TBL] [Abstract][Full Text] [Related]
8. Complement-binding anti-HLA antibodies are independent predictors of response to treatment in kidney recipients with antibody-mediated rejection.
Viglietti D; Bouatou Y; Kheav VD; Aubert O; Suberbielle-Boissel C; Glotz D; Legendre C; Taupin JL; Zeevi A; Loupy A; Lefaucheur C
Kidney Int; 2018 Oct; 94(4):773-787. PubMed ID: 29801667
[TBL] [Abstract][Full Text] [Related]
9. Significance and implications of capillaritis during acute rejection of kidney allografts.
Cosio FG; Lager DJ; Lorenz EC; Amer H; Gloor JM; Stegall MD
Transplantation; 2010 May; 89(9):1088-94. PubMed ID: 20216485
[TBL] [Abstract][Full Text] [Related]
10. Pathology of chronic humoral rejection.
Colvin RB
Contrib Nephrol; 2009; 162():75-86. PubMed ID: 19001815
[TBL] [Abstract][Full Text] [Related]
11. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.
Sis B; Halloran PF
Curr Opin Organ Transplant; 2010 Feb; 15(1):42-8. PubMed ID: 20009933
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Microvascular Inflammation in ABO-Incompatible Kidney Transplantation.
Ishihara H; Ishida H; Unagami K; Hirai T; Okumi M; Omoto K; Shimizu T; Tanabe K
Transplantation; 2017 Jun; 101(6):1423-1432. PubMed ID: 27495756
[TBL] [Abstract][Full Text] [Related]
13. Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes.
Batal I; Mohan S; De Serres SA; Vasilescu ER; Tsapepas D; Crew RJ; Patel SS; Serban G; McCune K; Husain SA; Chang JH; Herter JM; Bhagat G; Markowitz GS; D'Agati VD; Hardy MA; Ratner L; Chandraker A
Kidney Int; 2018 May; 93(5):1227-1239. PubMed ID: 29544662
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody in kidney transplant recipients with allograft dysfunction.
Chung BH; Kim JH; Choi BS; Park CW; Kim JI; Moon IS; Kim YS; Choi YJ; Oh EJ; Yang CW
Korean J Intern Med; 2018 Jan; 33(1):157-167. PubMed ID: 27764540
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological analysis of transplant glomerulopathy cases.
Shimizu T; Ishida H; Shirakawa H; Omoto K; Tsunoyama K; Iida S; Tanabe K; Yamaguchi Y
Clin Transplant; 2009 Aug; 23 Suppl 20():39-43. PubMed ID: 19594595
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular significance of microvascular inflammation in transplant kidney biopsies.
Gupta A; Broin PÓ; Bao Y; Pullman J; Kamal L; Ajaimy M; Lubetzky M; Colovai A; Schwartz D; de Boccardo G; Golden A; Akalin E
Kidney Int; 2016 Jan; 89(1):217-25. PubMed ID: 26422506
[TBL] [Abstract][Full Text] [Related]
17. Pathology of C4d-negative antibody-mediated rejection in renal allografts.
Haas M
Curr Opin Organ Transplant; 2013 Jun; 18(3):319-26. PubMed ID: 23283250
[TBL] [Abstract][Full Text] [Related]
18. The diffuse extent of peritubular capillaritis in renal allograft rejection is an independent risk factor for graft loss.
Kozakowski N; Herkner H; Böhmig GA; Regele H; Kornauth C; Bond G; Kikić Ž
Kidney Int; 2015 Aug; 88(2):332-40. PubMed ID: 25738252
[TBL] [Abstract][Full Text] [Related]
19. Microvascular inflammation in early protocol biopsies of renal allografts in cases of chronic active antibody-mediated rejection.
Tsuji T; Yanai M; Itami H; Ishii Y; Akimoto M; Fukuzawa N; Harada H; Fukasawa Y
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():26-30. PubMed ID: 26031582
[TBL] [Abstract][Full Text] [Related]
20. Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels.
Issa N; Cosio FG; Gloor JM; Sethi S; Dean PG; Moore SB; DeGoey S; Stegall MD
Transplantation; 2008 Sep; 86(5):681-5. PubMed ID: 18791449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
